Equinox's Longevity Membership, Meta's Smartwatch, Grail's Cancer Screening
Get every episode summarized
Each time Fitt Insider publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
About this episode
February 23, 2026: Your daily rundown of health and wellness news, in under 5 minutes.
Today's top stories:
-
Meta plans smartwatch launch later this year with health tracking and AI features, potentially integrating with Ray-Ban glasses ecosystem
-
Grail's $949 Galleri blood test fails to show statistically significant reduction in late-stage cancer diagnoses in major U.K. trial, stock falls sharply
-
Equinox's $40K/year Optimize membership hits 1,000+ person waitlist, including biomarker testing, training, and health concierge
More from Fitt:
Fitt Insider breaks down the convergence of fitness, wellness, and healthcare — and what it means for business, culture, and capital.
Subscribe to our newsletter → insider.fitt.co/subscribe
Work with our recruiting firm → https://talent.fitt.co/
Follow us on Instagram → https://www.instagram.com/fittinsider/
Follow us on LinkedIn → linkedin.com/company/fittinsider
Reach out → [email protected]
Get every episode summarized
Each time Fitt Insider publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Fitt Insider
Oura Pauses IPO, Tiny Health Raises $33M, RFK Jr.'s Food Push Stalls
Fitt Insider
Functional Shots Surge, Graza Explores Sale, Surgery Gets Scrutinized
Fitt Insider
358. Kate Ryder, Founder & CEO of Maven Clinic
Fitt Insider
Wearables Funding Surges, Brain Tech Raises $250M, GRAIL Nears FDA Decision
Fitt Insider